In an attempt to solve the third consecutive year of medicine shortages, the government is changing medicine acquisition processes.
General Manager North Latin America Region
There is no doubt that COVID-19 has changed the behavior of practically every industry, and the pharmaceutical market is no exception.
Fernando Becerril Orta
Becerril, Coca & Becerril – BC&B
New health-related laws and regulations are creating new challenges for the industry. BC&B’s Fernando Becerril explains.
Hospital pharmacies are receiving high-risk drugs in Dutch, Russian and Arabic, which no one can read. The risk to patients is massive.
Olivares Partner Armando Arenas outlines the “notorious inconsistencies” in the government’s procurement deal with the UN.
CANIFARMA (National Chamber of the Pharmaceutical Industry)
There are factors that impact the availability of vaccine doses directly and some others that could compromise the supply of medicines in general.